fulminant hepatitis 中文意思是什麼

fulminant hepatitis 解釋
暴發型肝炎
  • fulminant : adj. 1. 電閃雷鳴的，轟鳴的。2. 【醫學】（疾病）急性的，爆發性的。
  • hepatitis : n. 【醫學】肝炎。 infectious [serum] hepatitis 傳染性[血清]肝炎。
  1. Results the treatment group was superior significantly to the control group in the field of reduction of serum total bilirubin, the total bile acid, the total effective rates, advance of prothrombin activity ( pta ) and alph fetal protein ( afp ) of chronic fulminant hepatitis and the effective rates of the treatment group ( p < 0. 05 )

    結果治療組在降低血清總膽紅素、總膽汁酸、升高凝血酶原活動度、維持較高血清甲胎蛋白水平、提高存活率等方面均優于對照組，差異有顯著性（ p < 0 . 05或0 . 01 ） 。
  2. Clinical analysis of plasma exchange for 64 patients with fulminant hepatitis

    血漿置換治療重型肝炎64例臨床分析
  3. Fulminant viral hepatitis

    暴發性病毒性肝炎
  4. Result the highest mortality of fulminant hepatitis was among patients with chronic hepatitis b

    結果重型肝炎的病死率仍以慢性乙型肝炎為高。
  5. Effect of oxymatrine on murine fulminant hepatitis and hepatocyte apoptosis

    氧化苦參堿對小鼠暴發型肝炎及肝細胞凋亡作用的研究
  6. Conclusion the primary measure to reduce the mortality of fulminant hepatitis is to take precautionary measures to reduce the secondary infections in hepatitis b patients

    結論降低重型肝炎的病死率首先做好預防，減少乙型肝炎病人的繼發感染。
  7. Viral hepatitis a rarely leads to signficant necrosis, but hepatitis b can result in a fulminant hepatitis with extensive necrosis

    甲肝很少引起顯著的壞死，但乙肝能夠導致廣泛肝細胞壞死的爆發型肝炎。
  8. The keystone in reducing the mortality of fulminant hepatitis is to avoid the secondary impairment caused by immunopathology and enterogenous endotoxin and take active measures to prevent and treat all complications

    早期阻止免疫病理和腸源性內毒素的繼發性損傷，積極預防和治療各種並發癥是降低重型肝炎病死率的關鍵。
  9. So the prevention and therapy of fulminant hepatitis is still a very important problem

    重肝的防治，仍是現今肝病研究的重大課題。
  10. Objective to evaluate the efficacy and safety of prostaglandin e1 for treatment of chronic fulminant hepatitis

    摘要目的評價脂微球載體前列腺素對慢性重型肝炎患者血清甲胎蛋白及其預后的影響。
  11. Objective to investigate the death causation and complications of fulminant hepatitis and explore measures to improve the survival rate

    摘要目的探討重型肝炎的死亡原因及主要並發癥，以進一步提高存活率。
  12. Methods 58 cases of chronic fulminant hepatitis patients were randomly divided into the treatment group ( n = 29 ) and the control group ( n = 29 ) to receive prostaglandin e1 for three weeks

    方法將58例慢性重型肝炎患者隨機、平均分為脂微球載體前列腺素治療組與對照組，療程3周。
分享友人
分享到 Line

分享到臉書